Your session is about to expire
← Back to Search
Behavioral Intervention
Hospital-Based Treatment for Opioid Use Disorder
N/A
Recruiting
Led By Susan L Calcaterra, MD
Research Sponsored by University of Colorado, Denver
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up calculate mean monthly cows scores over a three year time frame (including pre and post implementation) to assess for change
Awards & highlights
No Placebo-Only Group
Summary
"This trial introduced a new treatment program for opioid use disorder in 12 hospitals in Colorado to help adults with opioid use disorder who are hospitalized."
Who is the study for?
This trial is for hospitalized adults in Colorado who are diagnosed with Opioid Use Disorder (OUD) and are experiencing a gap in treatment. Specific eligibility criteria details were not provided, so it's important to contact the study organizers for more information.
What is being tested?
The trial is testing an intervention designed to improve OUD treatment among hospitalized patients across 12 hospitals. It aims to address the current shortcomings in care for individuals suffering from opioid addiction.
What are the potential side effects?
Since specific interventions and their side effects aren't detailed, potential participants should ask the research team about what treatments are involved and any associated risks or side effects.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ calculate monthly prescribing rates over a three year time frame (including pre and post implementation) to assess for change
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~calculate monthly prescribing rates over a three year time frame (including pre and post implementation) to assess for change
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Change in buprenorphine prescribing at hospital discharge
Secondary study objectives
Change in rates of methadone prescribing during hospitalization
Other study objectives
Change in average (mean) COWS score over time
Change in naloxone prescribing at hospital discharge
Awards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
1Treatment groups
Experimental Treatment
Group I: OUD interventionExperimental Treatment1 Intervention
Participants received education on the diagnosis and management of OUD, have access to protocols to walk them through assessment of OUD using Diagnostic and Statistical Manual, fifth Edition (DSM)-5, COWS score to calculate severity of opioid withdrawal, buprenorphine or methadone initiation with pre-populated orders, and clickable links for OUD treatment referral post discharge.
Find a Location
Who is running the clinical trial?
University of Colorado, DenverLead Sponsor
1,810 Previous Clinical Trials
2,919,700 Total Patients Enrolled
National Institute on Drug Abuse (NIDA)NIH
2,607 Previous Clinical Trials
3,329,535 Total Patients Enrolled
Susan L Calcaterra, MDPrincipal InvestigatorUniversity of Colorado, Denver